Page last updated: 2024-09-03
3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and pravastatin
3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with pravastatin in 2 studies
Compound Research Comparison
| Studies (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Trials (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Recent Studies (post-2010) (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Studies (pravastatin) | Trials (pravastatin) | Recent Studies (post-2010) (pravastatin) |
|---|---|---|---|---|---|
| 100 | 6 | 38 | 3,575 | 1,036 | 816 |
Protein Interaction Comparison
| Protein | Taxonomy | 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (IC50) | pravastatin (IC50) |
|---|---|---|---|
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.1452 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.0056 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0056 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0254 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.6 |
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Furukubo, T; Izumi, S; Minegaki, T; Nishiguchi, K; Oda, T; Ogino, H; Shinmoto, T; Tachiki, H; Tsujimoto, M; Uchiyama, H; Yamakawa, T; Yoshida, T | 1 |
| Ichimura, Y; Ideuchi, H; Oda, M; Saitoh, H; Takamatsu, H; Takeda, K | 1 |
Other Studies
2 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and pravastatin
| Article | Year |
|---|---|
Uremic toxins enhance statin-induced cytotoxicity in differentiated human rhabdomyosarcoma cells.
Topics: Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Survival; Drug Synergism; Furans; Hippurates; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indican; Indoleacetic Acids; Pravastatin; Propionates; Rhabdomyosarcoma; Simvastatin; Toxins, Biological; Uremia | 2014 |
[Plasma concentrations of anionic uremic toxins in hemodialysis patients and their effects on protein binding of pravastatin].
Topics: Aged; Aged, 80 and over; Female; Furans; Humans; Indican; Indoleacetic Acids; Male; Middle Aged; Pravastatin; Propionates; Protein Binding; Renal Dialysis; Serum Albumin | 2015 |